Does an inflammatory pattern at primary biopsy suggest a lower risk for prostate cancer at repeated saturation prostate biopsy?

Urologia Internationalis

Volumn 87, Issue 2, 2011, Pages 171-174

  Pepe, Pietro ^a   Aragona, Francesco ^a  

^a CANNIZZARO HOSPITAL   (Italy)

Author keywords

Prostate cancer; Prostatitis; Repeated biopsy; Saturation prostate biopsy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACUTE DISEASE; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHRONIC PROSTATITIS; DIGITAL RECTAL EXAMINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATITIS; REPEAT PROCEDURE; SATURATION PROSTATE BIOPSY;

BIOPSY; CELL PROLIFERATION; HUMANS; INFLAMMATION; MALE; MEDICAL ONCOLOGY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATITIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 80052734802     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000328043     Document Type: Article

References (25)

1. Yaman O, Gogus C, Tulunay O, Tokatti Z, Ozden E: Increased PSA in subclinical prostatitis: The role of aggressiveness and extension of inflammation. Urol Int 2003; 71: 160-164. (Pubitemid 36928786)
2. Hochreiter WW: The issue of prostate cancer evaluation in men with elevated PSA and chronic prostatitis. Andrologia 2008; 40: 130-133. (Pubitemid 351379665)
3. Stopiglia RM, Ferreira U, Silva MM, Matheus WE, Denardi F, Reis LO: PSA decrease and prostate cancer diagnosis: Antibiotic versus placebo prospective randomized clinical trial. J Urol 2010; 183: 940-944.
4. Serretta V, Catanese A, Daricello G, et al: PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patients. Prostate Cancer Prostatic Dis 2008; 11: 148-152. (Pubitemid 351676603)
5. Tang P, Xie KJ, Wang B, Deng XR, Ou RB: Antibacterial therapy improves the effectiveness of prostate cancer detection using PSA in patients with asymptomatic prostatitits. Int Urol Nephrol 2010; 42: 13-18.
6. Carver BS, Bozeman CB, Williams BJ, Venable DD: The prevalence of men with NIH category IV prostatitis and association with serum PSA. J Urol 2003; 169: 589-591.
7. Kobayashi M, Nukui A, Morita T: Serum PSA and percent free PSA value changes after antibiotic treatment. A diagnostic method in prostate cancer suspects with asymptomatic prostatitis. Urol Int 2008; 80: 180-192.
8. Kaygisiz O, Ugurlu O, Kosan M, Inal G, Ozturk B, Cetinkaya M: Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/ml. Prostate Cancer Prostatic Dis 2006; 9: 235-238. (Pubitemid 44317256)
9. Krieger JN, Nyberg L Jr, Nieckel JC: NIH consensus definition and classification of prostatitis. JAMA 1999; 282: 236-237. (Pubitemid 29343164)
10. Martinez Fierro ML, Leach RJ, Gomez-Guerra LS, et al: Identification of viral infections in the prostate and evaluation of their association with cancer. BMC Cancer 2010; 10: 326-332.
11. Nelson WG, De Marzo AM, De Weese TL, Isaacs WB: The role of inflammation in the pathogenesis of prostate cancer. J Urol 2004; 172: 6-11.
12. De Marzo AM, Platz EA, Sutcliffe S, et al: Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7: 256-269. (Pubitemid 46486616)
13. Karakiewicz PI, Benayoun S, Begin LR, et al: Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy. Int J Clin Pract 2007; 61: 425-430.
14. Wang W, Bergh A, Damber JE: Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. Prostate 2009; 69: 1378-1386.
15. Aragona F, Pepe P, Motta M, et al: Incidence of prostate cancer in Sicily: Results of a multicenter case-findings protocol. Eur Urol 2005; 47: 569-574. (Pubitemid 40521897)
16. Pepe P, Aragona F: Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation. Urology 2007; 70: 1131-1135. (Pubitemid 350297372)
17. Karazanashvili G, Managadze L: Prostatespecific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng/ml and nonsuspicious results of digital rectal examination. Eur Urol 2001; 39: 538-543. (Pubitemid 32678968)
18. Kandirali E, Boran C, Serin E: Association of extent and aggressiveness of inflammation with serum PSA levels and PSA density in asymptomatic patients. Urology 2007; 70: 743-747. (Pubitemid 350030236)
19. Schaeffer AJ, Wu SC, Tennenberg AM, Kahn JB: Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum PSA. J Urol 2005; 174: 161-164. (Pubitemid 40825702)
20. Erol H, Beder N, Caliskan T, Dundar M, Unsal A, Culhaci N: Can the effect of antibiotic therapy and anti-inflammatory therapy on serum PSA levels discriminate between benign and malign prostatic pathologies? Urol Int 2006; 76: 20-26. (Pubitemid 43087516)
21. Magri V, Trinchieri A, Montanari E, et al: Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: Implications for prostate cancer detection. Arch Ital Urol Androl 2007; 79: 84-92. (Pubitemid 47122189)
22. Terrone C, Poggio M, Bollito E, Cracco CM, Scarpa RM: Asymptomatic prostatitis: A frequent cause of raising PSA (in Italian). Recenti Prog Med 2005; 96: 365-369. (Pubitemid 41078769)
23. Shtricker A, Shefi S, Ringel A, Gillon G: PSA levels of 4.0-10 ng/ml and negative digital rectal examination. Antibiotic therapy versus immediate prostate biopsy. Int Braz J Urol 2009; 35: 551-555.
24. Dirim A, Tekin MI, Koyluoglu E, Oguzulgen AI, Peskircioglu L, Ozkardes H: Do changes in high serum prostate-specific antigen level and the free/total PSA ratio after antibiotic treatment rule out biopsy and the suspicion of cancer̂ Urol Int 2009; 82: 266-269.
25. Molimard B, Camparo P, Desfemmes FR, Durand X, Haus R, Deligne E, Houlgatte A, Comperat E: Predictive value of asymptomatic prostatic inflammation in the development of prostate cancer. Prog Urol 2010; 20: 508-514.